Business
Personalis to Present New Data at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting
MENLO PARK, Calif.--(BUSINESS WIRE)-- Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced that the company will
About this update from Personalis, Inc.
[{"type":"text","content":" MENLO PARK, Calif.--(BUSINESS WIRE)--\nPersonalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced that the company will participate in the Society for Immunotherapy of Cancer (SITC) Annual Meeting, November 12-14, including online poster presentations and online industry sponsored symposium.\n\nThe company will showcase the Personalis NeXT Platform® which enables comprehensive analysis of both a tumor and its immune microenvironment from a single sample. The NeXT Platform™ can be used to investigate the key tumor and immune-related areas of cancer biology, consolidating multiple oncology biomarker assays into one and maximizing the biological information that can be generated from a precious tumor specimen.\n\nFollowing is a list of abstracts that will be presented online at the meeting.\n\nScientific Poster Presentations\n\n\n\nPoster Number & Category\n\n\n\nTitle & Presenter\n\n\n\nDay & Time\n\n\n\n\n\n19\n\n\nBiomarkers, Immune Monitoring, and Novel Technologies\n\n\n\nExome-scale liquid biopsy characterization of emerging immune resistance mechanisms in treatment-resistant GIST\n\n\nPresenter: Charles W. Abbott, PhD\n\n\n\nNOV 12 -14 | Online\n\n\n \n\n\n\n\n\n20\n\n\nBiomarkers, Immune Monitoring, and Novel Technologies\n\n\n\nTumor-informed liquid biopsy monitoring of evolving therapeutic resistance mechanisms in head and neck squamous cell carcinoma patients receiving anti-PD-1 therapy\n\n\nPresenter: Charles W. Abbott, Ph.D.\n\n\n\nNOV 12 -14 | Online\n\n\n \n\n\n\n\n\n75\n\n\nBiomarkers, Immune Monitoring, and Novel Technologies\n\n\n\nComprehensive profiling of the tumor-immune microenvironment using an augmented transcriptome\n\n\nPresenter: Eric Levy, PhD\n\n\n\nNOV 12 -14 | Online\n\n\n \n\n\n\n\n\n79\n\n\nBiomarkers, Immune Monitoring, and Novel Technologies\n\n\n\nExtensively validated HLA LOH algorithm demonstrates an association between HLA LOH and genomic instability\n\n\nPresenter: Rachel M. Pyke, PhD\n\n\n\nNOV 12 -14 | Online\n\n\n \n\n\n\n\nFollowing are details of an industry-sponsored symposium which will be presented online at the meeting.\n\nIndustry Sponsor Symposium\n\n\n\nPresentation Category\n\n\n \n\nTitle & Presenter\n\n\n\nDay & Time\n\n\n\n\n\nSponsored Symposia\n\n\n \n\nLeveraging comprehensive genomic data for diagnostic capabilities and composite biomarker...